English  |  正體中文  |  简体中文  |  Items with full text/Total items : 94286/110023 (86%)
Visitors : 21691473      Online Users : 458
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/2517


    Title: Investigation of human salivary biomarkers for oral cancer using proteomics approach
    Authors: Yu-Jen Jou
    Contributors: Department of Biotechnology
    Keywords: oral cancer;proteomic;Matrix-Assisted Laser Desoption/Ionization Time-of-flight Mass Spectrometry (MALDI-TOF MS)
    Date: 2009
    Issue Date: 2009-11-06 06:11:36 (UTC+0)
    Publisher: Asia University
    Abstract: Oral cancer is one of the most frequent cancers worldwide. Tobacco, alcohol and betel quid chewing are the factors for oral cancer, being associated with the increase in the rate of oral cancer incidence in Taiwan. Early diagnosis of oral cancer can provide adequate treatment and increase survival. The goal of the study is to identify oral cancer-specific salivary biomarkers such as peptides and proteins using the proteomic approaches. We collected salivary samples from oral cancer-free individuals and oral cancer patients attended in the China Medical University hospital during 2008 and 2009. Firstly, commercial C8-functionalized magnetic beads were used for salivary peptide separations. C8- affinity peptides were incubated with the matrix 2,5-dihydroxyacetophenone (2,5-DHB) or a-cyano-4-hydroxycinnamic acid (HCCA), and then analyzed using Matrix-Assisted Laser Desoption/Ionization Time-of-flight Mass Spectrometry (MALDI-TOF MS). ClinProtTM Bruker Daltonic analyses revealed that unique mass peak of 4438 Da peptide in 2,5-DHB was in 10% of the saliva from oral cancer-free individuals and 41.18%of the saliva from oral cancer patients with the T2 stage. In addition, unique mass peak of 2918 Da peptide in HCCA was in 0% of the saliva from oral cancer-free individuals and 80%of the saliva from oral cancer patients with the T4 stage. Moreover, MALDI-TOF/TOF MS/MS revealed the amino acid sequence CNSWEVNLQSISEFIINNRNYSTK for 2918 Da peptide, being one fragment of the zinc finger protein 510 (ZNF510). ELISA and Western blotting assays confirmed the amount of 2918 Da peptide in saliva using rabbit polyclonal sera against the 2918 Da peptide. In addition, transferring was identified as the up-regulated protein in the saliva from oral cancer patients using two-dimension gel electrophoresis (2DE) and MALDI-TOF MS. ELISA and Western blotting assays showed a significantly higher protein level in the saliva from oral cancer patients than the saliva from oral cancer-free individuals. The study identified 2918 Da peptide and transferring as oral cancer-specific salivary biomarkers using the proteomic approaches, being helpful for developing the diagnostic kids for oral cancer.
    Appears in Collections:[生物科技學系] 博碩士論文

    Files in This Item:

    File Description SizeFormat
    0KbUnknown810View/Open
    2517.doc26KbMicrosoft Word238View/Open


    All items in ASIAIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback